70%Confidence
0Views
FDASource
2026-04-14Date
Summary
Radnostix's Class III recall for failed capsule specifications in a diagnostic kit component is a low-risk issue but indicates manufacturing inconsistencies. This may have minimal market impact but could affect niche diagnostic procedures.
Actionable: Monitor for any follow-up recalls in Radnostix's product lines.
AI Confidence: 70%
Data Points
firmRadnostix
classificationClass III
statusOngoing
distributionNationwide in the US, including Puerto Rico
productGelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, Internation
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now